These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31889045)

  • 1. Expression of Dual-Specificity Phosphatase 2 (DUSP2) in Patients with Serous Ovarian Carcinoma and in SKOV3 and OVCAR3 Cells In Vitro.
    Liu W; Tian X; Ding X; Zhang L
    Med Sci Monit; 2019 Dec; 25():10180-10189. PubMed ID: 31889045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.
    Yin H; He W; Li Y; Xu N; Zhu X; Lin Y; Gou X
    Hum Pathol; 2019 Mar; 85():152-161. PubMed ID: 30458195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target.
    Wang H; Ye F; Zhou C; Cheng Q; Chen H
    PLoS One; 2021; 16(2):e0245733. PubMed ID: 33635867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
    Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
    Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
    Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
    Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
    Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
    Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
    Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.
    Lee M; Nam EJ; Kim SW; Kim S; Kim JH; Kim YT
    Int J Gynecol Cancer; 2012 Nov; 22(9):1489-96. PubMed ID: 23095773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine-fructose-6-phosphate transaminase 2 (GFPT2) promotes the EMT of serous ovarian cancer by activating the hexosamine biosynthetic pathway to increase the nuclear location of β-catenin.
    Zhou L; Luo M; Cheng LJ; Li RN; Liu B; Linghu H
    Pathol Res Pract; 2019 Dec; 215(12):152681. PubMed ID: 31685298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
    Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
    Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1.
    Han S; Zhu J; Zhang Y
    Med Sci Monit Basic Res; 2018 Feb; 24():40-46. PubMed ID: 29445078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2).
    Qin Y; Chen X; Liu Z; Tian X; Huo Z
    Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.
    Park SH; Song JY; Kim YK; Heo JH; Kang H; Kim G; An HJ; Kim TH
    Int J Oncol; 2014 Mar; 44(3):637-46. PubMed ID: 24378809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma.
    Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K
    Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of dihydroartiminisin on proliferation and phosphorylation of mitogen-activated protein kinase in epithelial ovarian cancer cell lines].
    Tan XJ; Plouet J; Lang JH; Wu M; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):662-5. PubMed ID: 19087515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of dihydroartiminisin on the adhesion, migration, and invasion of epithelial ovarian cancer cells].
    Tan XJ; Lang JH; Plouet J; Wu M; Shen K
    Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2642-6. PubMed ID: 19080714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.